Mixed Streptococcus pneumoniae and Streptococcus pyogenes meningitis in an immunocompromised adult patient: a case report by Clémence Demerle et al.
CASE REPORT Open Access
Mixed Streptococcus pneumoniae and
Streptococcus pyogenes meningitis in an
immunocompromised adult patient: a case
report
Clémence Demerle1, Vadim Ivanov2, Cédric Mercier2, Régis Costello2 and Michel Drancourt1,3*
Abstract
Introduction: Community-acquired meningitis is a monomicrobial infection caused by either viruses or bacteria in
the vast majority of patients. We report here one exceptional case of a patient with mixed bacterial meningitis due
to Streptococcus pneumoniae and Streptococcus pyogenes.
Case presentation: We report the case of a 68-year-old immunocompromised Caucasian man suffering from otitis
and then meningitis caused by Streptococcus pneumoniae and Streptococcus pyogenes. Bacteria were
undistinguishable by direct microscopic examination of the cerebrospinal fluid. He responded well to treatment
with cefotaxime and dexamethasone, with no sequelae observed at the 4-month follow-up.
Conclusions: This first reported case of mixed S. pneumoniae and S. pyogenes meningitis illustrates the life-
threatening consequences of barotrauma in immunocompromised patients suffering from otorhinolaryngeal
infections.
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Introduction
Community-acquired meningitis is a monomicrobial
infection caused by only one pathogen, either a virus
or a bacterium, in the vast majority of patients. Among
bacterial pathogens responsible for meningitis, the
prevalence of Streptococcus pneumoniae is declining,
although this organism is still responsible for more
than 50 % of bacterial meningitis cases [1]. It is diag-
nosed by real-time polymerase chain reaction (PCR)-based
detection of specific DNA sequences in the cerebrospinal
fluid (CSF), yet direct microscopic examination of the CSF
after Gram staining is routinely used as a screening method
to establish a presumptive etiology [2]. Part of the relative
specificity of Gram staining is based on the common fact
that only one bacterium should be detected in the CSF.
We report here one exceptional case of a patient with
mixed bacterial meningitis due to S. pneumoniae and
Streptococcus pyogenes where routine Gram staining was
not reliable for the final diagnosis.
Case presentation
A 68-year-old Caucasian man was admitted 1 day after
flying back from Madagascar to Marseille, France. He
was in remission from chronic lymphoid leukemia with
no chemotherapy for 6 months and had had unilateral
purulent otorrhea for several days. At the time of ad-
mission, our patient’s temperature was 38 °C and he
presented with a stiff neck and confusion. His left ear
was painful and inflamed, and an examination
revealed pus without tympanic membrane perforation.
A cranial computed tomography (CT) scan showed
evidence of a left mastoid infection without bone erosion,
cholesteatoma or brain abscess. Ear pus was sampled by
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Sigma-Transwab (Elitech France, Puteaux, France). CSF
was collected after a lumbar puncture and our patient re-
ceived 300 mg/kg cefotaxime and 20 mg dexamethasone
[3, 4]. Relevant biological parameters included pan-
cytopenia with 3.68 T/L red cells, a hemoglobin level
of 117 g/L, and 1.13 G/L leukocytes including 0.39
G/L lymphocytes and 74 G/L platelets. Appropriate
point-of-care (POC) tests excluded malaria, dengue
and Chikungunya viral infections [5].
Direct microscopic examination of the Gram-stained
CSF revealed 930 polymorphonuclear cells and 170 red
cells per cubic millimeter, along with numerous Gram-
positive cocci. Our patient’s CSF contained 3.63 g/L
total protein and 1.31 mmol/L glucose. S. pneumoniae
antigen detection was positive (BinaxNOW, Alere,
Jouy-en-Josas, France) [6] along with positive real-time
PCR detection of S. pneumoniae Lyt-A and Ply-N
genes with cycle thresholds of 33 and 34, respectively.
POC real-time PCR detection of enterovirus, herpes-
virus, varicella-zoster virus and Neisseria meningitidis
remained negative in the CSF [5]. CSF grew colonies on
chocolate agar and 5 % sheep-blood agar (bioMérieux,
Marcy l’Etoile, France) after a 5-day incubation period at
37 °C under a 5 % CO2 atmosphere. Colonies were
identified as S. pyogenes by matrix-assisted laser
desorption-ionization time-of-flight mass spectrometry
(MALDI-TOF-MS) with an identification score of 2.26
[7]. Antibiotic susceptibility testing using the disk dif-
fusion method found the S. pyogenes isolate to be
susceptible (according to EUCAST guidelines) to
amoxicillin [minimum inhibitory concentration (MIC),
0.250 mg/L], ceftriaxone (MIC, 0.5 mg/L), rifampicin
(MIC, 0.052 mg/L), clindamycin (MIC, 0.4 mg/L) and
doxycycline (MIC, 4 mg/L), but resistant to erythromycin
(MIC, 1 mg/L). S. pneumoniae was not cultured from the
CSF, though both S. pneumoniae and S. pyogenes were cul-
tured from the ear pus after 1-day and 2-day incubations
at 37 °C and 5 % CO2, respectively. Colonies were identi-
fied by MALDI-TOF-MS with identification scores of 2.22
and 2.35, respectively. The ear pus S. pyogenes isolate
exhibited the same antibiotic susceptibility pattern as the
CSF S. pyogenes isolate. The antibiotic susceptibility of the
ear pus S. pneumoniae isolate, tested by using the E-test
method (BioMérieux), indicated in vitro susceptibility to
penicillin (MIC, 0.012 mg/L), amoxicillin (0.016 mg/L),
ceftriaxone (0.016 mg/L), imipenem (0.004 mg/L) and
vancomycin (0.250 mg/L). Susceptibility testing to oxacillin,
gentamicin, erythromycin, rifampicin, clindamycin and
doxycycline by using the disk diffusion method found the
isolate to be susceptible to all these antibiotics.
One day after admission, our patient suffered
epileptic seizures resistant to 1 mg clonazepam. An
electroencephalogram confirmed status epilepticus
and our patient was given sodium valproate and
levetiracetam and was admitted to the intensive care
unit. Cefotaxime (18 gr/day) was intravenously adminis-
tered with a syringe pump for 14 days in association with
dexamethasone the first day. Our patient eventually
recovered after 4 weeks of hospitalization. A follow-
up at 4 months postdischarge found no sequelae.
The otolaryngologist prescribed long-term treatment
with amoxicillin to prevent any further otitis.
Conclusions
In this patient, mixed meningitis due to both S.
pneumoniae and S. pyogenes was not initially sus-
pected after direct microscopic examination of the
CSF disclosed Gram-positive cocci. Indeed, although
subtle microscopic differences have been reported
that distinguish both streptococci, they are unreliable for
prospectively distinguishing between both pathogens in
routine practice. Detection of S. pneumoniae antigen by
using immunochromatographic tests and real-time PCR,
however, enables rapid detection of S. pneumoniae in the
CSF at the point of care [5].
Moreover, the case here reported of a mixed infection
is exceptional as no such case has ever been previously
reported. Indeed, while S. pneumoniae is the leading
bacterial etiology of purulent meningitis in adults [1], S.
pyogenes meningitis is by itself a rare condition, and is
reported in a total of 29 adult patients, including the
one reported here [8–11]. S. pyogenes meningitis has a
poor prognosis; six patients died and most of the other
patients showed neurological complications (Table 1).
That was not the case for the patient reported here.
In our patient, purulent otitis was confirmed as the
portal of entry by culture of both S. pneumoniae and S.
pyogenes exhibiting the same antibiotic susceptibility
Table 1 Review of main characteristics of Streptococcus
pyogenes meningitis cases in the literature
Characteristic of the 29 patients
Age (median, years) 45





Otitis 23 (79 %)
Sinusitis 7 (24 %)
Outcome
Acute neurological complications 19 (66 %)
Neurologic sequelae 11 (38 %)
Hearing loss 4 (14 %)
Death 6 (21 %)
CSF cerebrospinal fluid
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pattern as the CSF isolate. We hypothesized that in this
patient with purulent otitis, a 12-hour flight led to a
barotraumatic breach of the tympanus and central
nervous system infection. Barotrauma following flight
has been previously reported [12]. Moreover, one simi-
lar case of S. pneumoniae meningitis following pneumococ-
cal otitis after scuba diving has been described [13].
Patients diagnosed with chronic lymphocytic leukemia, as
was the case in the patient here reported, are at increased
risk of systemic infection by encapsulated bacteria such as
S. pneumoniae. In such patients, pancytopenia at the time
of admission is an additional risk factor [14].
In the patient reported here, both streptococci tested
susceptible to cefotaxime, the empirical treatment ad-
ministered to our patient and successfully continued for
14 days. This case indicates that immunocompromised
patients should avoid barotrauma when presenting with
acute uncontrolled bacterial otitis. Concerning their
sensitivity to pneumococcal infections, patients should
be offered the 13-valent pneumococcal conjugate vac-
cine at the time of their chronic lymphoid leukemia
diagnosis [15].
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